-
Protein Drug Discovery Company Launches, Gains $50M
A biotechnology enterprise founded by faculty at Scripps Research Institute plans to discover new therapies based on complex interactions with human proteins.
-
Asthma Drug Tested as Alcoholism Treatment
Results from a small-scale clinical trial show an established drug to treat asthma and other inflammatory conditions has promise as a treatment for alcohol dependence.
-
EU Project to Develop More Versatile Heart Pacemakers
An initiative in Europe plans to design a new type of pacemaker device that adapts to a host of signals in the cardiovascular system and regulates multiple heart functions.
-
Grid Computing Harnessed for Childhood Cancer Research
An international consortium is seeking crowdsourced computing power to screen drug candidates for treating a number of cancers affecting children.
-
Low-Cost Skin Hydration Sensor and Systems Designed
Engineers at North Carolina State University in Raleigh developed a hydration sensor worn on the skin and built into two low-cost prototype wearable systems.
-
Smart Watch Software Designed to Verify Signatures
Engineering researchers in Israel created software that enables smart watches and fitness bands to capture wrist movements for verifying a person’s signature.
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.
-
Science Org. CEO: Trump Order “Contrary to Science”
The chief executive officer of the world’s largest general science organization called the Trump administration’s order detaining travelers from Muslim countries to the U.S., including scientists and students, “contrary to the spirit of science.”
-
Immunotherapy Biotech Raises $102 Million in IPO
A biotechnology company developing treatments for solid tumors, harnessing the body’s immune system, for cancer patients most likely to respond is raising $102 million in its initial public stock offering.
-
Simpler Lab Cell Production Techniques Devised
A process is being developed that makes it easier to produce healthy and diseased cells in the lab from human specimens for regenerative medicine and research.